Chi Van Dang
Scientific Director, Ludwig Cancer Research
Meet Chi Van Dang
Chi is well-known for his contributions to the understanding of the Myc oncogene – his research has led to studies dedicated to the targeted disruption of aberrant cell metabolic pathways, with the aim of developing drugs to inhibit cancer. “Patients dying of cancer remind me every day why I do what I do. As with everyone else, my life has been personally touched by cancer, and as a trained medical oncologist, I am humbled by cancer as a formidable foe. A career is a journey in continuous learning – I learn something new every day.”